Moderna’s Covid-19 Vaccine Gets A Nod In The Country – All You Need To Know

Drugs Controller General of India has approved Cipla, a pharmaceutical company based in Mumbai, to import Moderna vaccine for emergency use in the country, NITI Aayog member, VK Paul announced on Tuesday. Paul also added in the briefing, “The permission of new drug has been granted to Moderna, the first vaccine developed internationally. The permission of the new drug is for restricted use.”

The fourth vaccine is ready for a drive in India. The other three vaccines which are used currently in the country are Covaxin, manufactured by Bharat Biotech, Serum Institute of India’s Covishield, and Sputnik V, the Russian vaccine.

Also Read: When The Kids Can Go Back To School? The Director Of AIIMS Has The Answer

American pharmaceutical company has manufactured the Moderna vaccine with the same name. Here are the things to know about the international vaccine:

What is the Moderna vaccine?

It is also known as the mRNA-1273 vaccine. It is made with the help of messenger RNA, it is a technology that lets our cells know how protein is made – or only the piece – that triggers the immunization process inside our bodies.

How many shots are necessary?

The Moderna vaccine has two doses which will be given at the interval of 28 days. India will also get in two doses, confirmed by Paul in the briefing. However, the interval period is yet to be announced in India.

Is it approved by World Health Organization (WHO)?

World Health Organization has approved the vaccination. It was approved on April 30, 2021, after the recommendation of its strategic advisory group of experts (SAGE).

Is the vaccine effective?

It has been shown that the vaccine has an efficacy rate of about 95% in keeping a person safe from Covid-19. It has been mentioned on the website of WHO that immunity starts developing after 14 days of the first dose.

Will it be effective against new variants?

As per the studies shown so far, the Moderna vaccine works well against the new variants of SARS-CoV-2, which include the Beta version (501Y.V2) and Alpha variant (B.1.1.7).

However, research is still going on to know how useful the vaccine is against the new variants.

In how many countries the vaccine is approved?

Currently, the vaccine has been approved by more than 45 countries, which include United States, Canada, United Kingdom, Germany, Israel, France, South Korea, Italy, and Japan.

Are there any side effects?

The side effects are minor and no major ones are involved. However, after the dose, a person might feel a slight fever, chills, and soreness in the arm. Some of the after-effects are nausea, body ache, and fatigue.

What are the age groups who can get the vaccine?

Any person above the age of 18+ can get the vaccination, approved by WHO. As per the report, Moderna has requested with the European Medicines Agency to get the authorization for use in the 12-17 age group. The medical trial data of the FDA is also under review for use in an emergency in kids of 12 age and above.